New hope to save kidneys after heart transplant
NCT ID NCT04180085
Summary
This study is testing if a drug called belatacept can help protect the kidneys of heart transplant patients. Standard anti-rejection drugs can damage kidneys over time. Researchers want to see if using belatacept can reduce this kidney damage without increasing the risk of the body rejecting the new heart.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bertrand Lelong
RECRUITINGRennes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Claire Garandeau
RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karine Nubret
RECRUITINGBordeaux, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Laurent Sebbag
RECRUITINGLyon, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.